Levofloxacin
Is It Right for You?
A complete guide to Levofloxacin — what it treats, how it works, dosages, side effects, and when a clinician may prescribe it following an online consultation.
What Is Levofloxacin?
Levofloxacin is a third-generation fluoroquinolone antibiotic available in tablets of 250 mg and 500 mg and as an intravenous infusion solution. It is the L-isomer of ofloxacin and possesses superior antibacterial activity compared to earlier fluoroquinolones. Levofloxacin is active against a broad range of gram-positive, gram-negative, and atypical organisms, making it valuable for the treatment of respiratory, urinary, and skin infections where other antibiotic classes are not appropriate or have failed.
In the UK, prescribing of fluoroquinolone antibiotics — including levofloxacin — has been significantly restricted following MHRA guidance (2019 and 2023) citing the risk of potentially serious, disabling, and long-lasting side effects, particularly musculoskeletal and neurological adverse reactions. Fluoroquinolones should now be used only when other appropriate antibiotic options are not available and the benefit-risk balance clearly favours their use.
Levofloxacin is a prescription-only medication in the UK. Its prescribing is subject to specific MHRA safety restrictions and should be initiated only after careful clinical assessment confirms no appropriate alternative.
What Conditions Is Levofloxacin Used For?
Levofloxacin is indicated for:
including atypical pneumonia caused by Legionella pneumophila, Mycoplasma pneumoniae, and Chlamydophila pneumoniae, which are intrinsically resistant to beta-lactam antibiotics; particularly valuable in penicillin-allergic patients
in selected patients where other antibiotics are inappropriate
when resistant organisms are identified or suspected, or as an alternative in patients allergic to first-line agents
complicated infections where gram-positive and gram-negative coverage is required
levofloxacin achieves excellent prostatic tissue penetration, making it effective for this difficult-to-treat indication
as part of specialist-directed combination regimens
Fluoroquinolone antibiotics including levofloxacin are associated with serious and potentially permanent adverse effects. Current MHRA and NICE guidance restricts their use to situations where other appropriate antibiotics are not suitable. They should not be used for mild infections, simple lower UTIs, or conditions where first-line antibiotics are effective. Antimicrobial stewardship principles must guide all prescribing decisions.
How Does Levofloxacin Work?
Levofloxacin belongs to the fluoroquinolone class of antibiotics, which exert their bactericidal activity through a mechanism unique among antibiotics — inhibition of bacterial DNA replication enzymes:
Topoisomerase inhibition: Bacterial DNA is tightly supercoiled and requires the action of type II topoisomerases — specifically DNA gyrase (topoisomerase II) and topoisomerase IV — to manage the topological stress created during DNA replication, transcription, and cell division. DNA gyrase introduces negative supercoils to relax positive supercoiling ahead of the replication fork; topoisomerase IV decatenates daughter chromosomes after replication.
Ternary complex formation and strand breaks: Levofloxacin binds to the DNA–gyrase and DNA–topoisomerase IV complexes at the moments when these enzymes have cut both strands of the DNA double helix. By stabilising these enzyme-DNA "cleavage complexes," levofloxacin traps the bacterial chromosome in a broken state, prevents re-ligation, and generates lethal double-strand DNA breaks that rapidly kill the bacterium.
Gram-positive vs. gram-negative selectivity: In gram-negative organisms, DNA gyrase is the principal target; in gram-positive organisms, topoisomerase IV is typically the primary target. Levofloxacin's activity against both enzyme types contributes to its broad spectrum of coverage.
Dosages & Administration
The correct dose depends on the type and severity of infection, age, weight, and kidney function. Always follow your clinician's instructions. The table below is for general reference only.
Administration Tips
Take tablets at the same time each day. Can be taken with or without food; food does not significantly affect absorption.
Take 2 hours before or 4–6 hours after antacids, iron, calcium, zinc, or dairy products. Polyvalent cations (aluminium, magnesium, calcium, iron, zinc) form chelation complexes with levofloxacin in the GI tract, dramatically reducing absorption by up to 90%; this is one of the most clinically important drug-food and drug-drug interactions for fluoroquinolones.
Stay well hydrated throughout the course. Adequate fluid intake reduces the risk of crystalluria and supports renal clearance.
Complete the full course. Do not stop early even if symptoms improve, as incomplete courses promote the selection of resistant organisms.
Avoid prolonged sun exposure. Levofloxacin causes photosensitivity; use high-SPF sunscreen and protective clothing when outdoors.
Stop immediately and contact your clinician if you develop tendon pain, muscle weakness, or neurological symptoms. These may be early signs of serious levofloxacin-associated toxicity.
Side Effects of Levofloxacin
Most side effects are mild and resolve on their own. Serious side effects are rare but require immediate medical attention.
- Nausea and diarrhoea --- the most common GI side effects
- Headache and dizziness
- Insomnia
- Photosensitivity --- increased susceptibility to sunburn and skin reactions
- Elevated liver enzymes (usually transient)
- Tendinitis and tendon rupture --- one of the most important fluoroquinolone class warnings; Achilles tendon rupture can occur during or up to several months after treatment, even after a short course; risk is highest in elderly patients, those on corticosteroids, and patients with renal impairment; any new tendon pain must result in immediate treatment cessation
- Peripheral neuropathy --- potentially permanent; numbness, tingling, burning pain, or weakness in the extremities; may persist for months to years after stopping treatment; stop immediately if symptoms develop
- CNS effects --- seizures, psychosis, hallucinations, anxiety, depression, confusion, and suicidal ideation; rare but recognised; risk higher in patients with CNS disorders
- QT interval prolongation and ventricular arrhythmias --- including torsades de pointes; avoid in patients with known QT prolongation; baseline ECG recommended in at-risk patients
Levofloxacin is associated with tendinitis and tendon rupture — most commonly the Achilles tendon — which can occur during treatment or up to several months after completion. Risk is highest in patients over 60, those on systemic corticosteroids, and those with renal impairment. Any new tendon pain, swelling, or inflammation must result in immediate discontinuation of levofloxacin and avoidance of exercise or strenuous activity pending clinical assessment.
Drug Interactions
Always disclose all prescription drugs, over-the-counter medicines, vitamins, and supplements to your clinician or pharmacist before starting Levofloxacin
chelation in the GI tract reduces levofloxacin absorption by up to 90%; must be separated by at least 2 hours before or 4–6 hours after levofloxacin.
concurrent NSAID use markedly increases the risk of levofloxacin-induced CNS stimulation and seizures; avoid combination where possible.
modest elevation of theophylline plasma levels; monitor theophylline levels.
reduces levofloxacin absorption; administer levofloxacin at least 2 hours before sucralfate.
Important Warnings
Levofloxacin is associated with tendinitis and tendon rupture — most commonly the Achilles tendon — which can occur during treatment or up to several months after completion. Risk is highest in patients over 60, those on systemic corticosteroids, and those with renal impairment. Any new tendon pain, swelling, or inflammation must result in immediate discontinuation of levofloxacin and avoidance of exercise or strenuous activity pending clinical assessment.
Peripheral neuropathy associated with fluoroquinolones can be severe, persistent, and potentially permanent. Symptoms include burning, tingling, numbness, or weakness in the hands and feet. Treatment must be stopped immediately if these symptoms develop and the patient referred for neurological assessment.
Fluoroquinolones are associated with an increased risk of aortic aneurysm and dissection. They should not be used in patients with known aortic aneurysm, or in patients at increased risk (family history, connective tissue disorders, hypertension) unless no alternative is available.
Levofloxacin can cause significant CNS adverse effects including seizures, psychosis, hallucinations, severe depression, and suicidal ideation. Patients with a history of seizures, psychiatric illness, or CNS disorders are at higher risk and require heightened monitoring.
Speak to a Clinician About Treatment
Getting advice no longer means sitting in a waiting room. Through The GP Service, you can consult with a licensed clinician in minutes — from home, on your lunch break, or wherever works for you. If treatment is clinically appropriate, your clinician can issue a prescription during the consultation. A consultation does not guarantee a prescription.
The treatment you need, when you need it.
Levofloxacin FAQs
Polyvalent metal ions — including calcium (in dairy and antacids), magnesium and aluminium (in antacids), and iron and zinc (in supplements) — bind to levofloxacin in the gastrointestinal tract, forming insoluble chelation complexes that are not absorbed. This can reduce levofloxacin absorption by up to 90%, rendering the antibiotic ineffective. Separate levofloxacin from any of these products by at least 2 hours before or 4–6 hours after the dose.
Stop taking levofloxacin immediately and contact your clinician without delay. Do not exercise or put strain on the affected tendon. Fluoroquinolone-associated tendinopathy can progress to complete tendon rupture — which is a serious injury requiring surgical repair — if treatment is not stopped promptly. This is a class-level warning that must be taken seriously.
MHRA guidance issued in 2019 and updated subsequently significantly restricted fluoroquinolone prescribing due to their risk of serious, disabling, and potentially permanent side effects — including tendinopathy, peripheral neuropathy, and CNS disturbance — which can occur even after a single short course. Fluoroquinolones are now reserved for situations where no appropriate alternative antibiotic is available.
Yes. Fluoroquinolone-associated psychiatric effects — including anxiety, agitation, insomnia, depression, confusion, hallucinations, and in rare cases suicidal ideation — are well documented. These can occur during treatment or after it has finished. If you notice significant mood or behavioural changes during a course of levofloxacin, contact your clinician promptly.
Yes. A constellation of adverse effects — including tendinopathy, peripheral neuropathy, psychiatric disturbance, fatigue, and cognitive difficulty — occurring together and persisting long after treatment has stopped is well documented in the medical literature and acknowledged by the MHRA. The mechanism is believed to involve mitochondrial toxicity and oxidative stress. It is one of the reasons fluoroquinolone prescribing has been so significantly restricted in the UK in recent years.